Skip to main content
Erschienen in: Supportive Care in Cancer 9/2012

01.09.2012 | Original Article

Swallowing, nutrition and patient-rated functional outcomes at 6 months following two non-surgical treatments for T1–T3 oropharyngeal cancer

verfasst von: Bena Cartmill, Petrea Cornwell, Elizabeth Ward, Wendy Davidson, Sandro Porceddu

Erschienen in: Supportive Care in Cancer | Ausgabe 9/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Altered fractionation radiotherapy with concomitant boost (AFRT-CB) may be considered an alternative treatment for patients not appropriate for chemoradiation (CRT). As functional outcomes following AFRT-CB have been minimally reported, this exploratory paper describes the outcomes of patients managed with AFRT-CB or CRT at 6 months post-treatment.

Methods

Using a cross-sectional analysis design, functional outcomes of 14 AFRT-CB and 17 CRT patients with T1–T3 oropharyngeal cancers were explored at 6 months post-treatment. Clinical and instrumental swallow assessments, weight and nutritional status, and the functional impact of treatment were examined.

Results

Inferior outcomes were observed for the CRT patients on the RBHOMS (p = 0.03) which was reflected in diet and fluid restrictions with 18% of the CRT group requiring modified fluids and diets. Although a trend (p = 0.07) was noted for increased lingual deficits and aspiration risk for fluids in the CRT group, no other significant differences were observed. Both groups experienced an average of 10 kg weight loss and reported reduced general and swallowing-related function.

Conclusions

These preliminary data suggest functional outcomes following AFRT-CB and CRT were largely comparable at 6 months post-treatment. Treatment intensification in any form may contribute to impaired function which requires multidimensional intervention. Larger cohort investigations with systematic methodology are needed to further examine these initial findings.
Literatur
1.
Zurück zum Zitat Adelstein D, Li Y, Adams G, Wagner H Jr, Kish J, Ensley J et al (2003) An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21(1):92–98PubMedCrossRef Adelstein D, Li Y, Adams G, Wagner H Jr, Kish J, Ensley J et al (2003) An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21(1):92–98PubMedCrossRef
2.
Zurück zum Zitat Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL et al (2000) A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48(1):7–16PubMedCrossRef Fu KK, Pajak TF, Trotti A, Jones CU, Spencer SA, Phillips TL et al (2000) A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48(1):7–16PubMedCrossRef
3.
Zurück zum Zitat Jackson S, Weir L, Hay J, Tsang V, Durham J (1997) A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer. Radiother Oncol 43(1):39–46PubMedCrossRef Jackson S, Weir L, Hay J, Tsang V, Durham J (1997) A randomised trial of accelerated versus conventional radiotherapy in head and neck cancer. Radiother Oncol 43(1):39–46PubMedCrossRef
4.
Zurück zum Zitat Caudell JJ, Schaner PE, Meredith RF, Locher JL, Nabell LM, Carroll WR et al (2009) Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 73(2):410–415PubMedCrossRef Caudell JJ, Schaner PE, Meredith RF, Locher JL, Nabell LM, Carroll WR et al (2009) Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 73(2):410–415PubMedCrossRef
5.
Zurück zum Zitat Logemann JA, Rademaker AW, Pauloski BR, Lazarus CL, Mittal BB, Brockstein B et al (2006) Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiation. Head Neck 28(1):64–73PubMedCrossRef Logemann JA, Rademaker AW, Pauloski BR, Lazarus CL, Mittal BB, Brockstein B et al (2006) Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiation. Head Neck 28(1):64–73PubMedCrossRef
6.
Zurück zum Zitat Yu K, Chua M, Vlantis A, Kam M, Lee W, Tsang R et al (2005) Swallowing function after altered fractionation radiotherapy for head and neck carcinoma. Journal Hong Kong College of Radiologists 8(4):207–213 Yu K, Chua M, Vlantis A, Kam M, Lee W, Tsang R et al (2005) Swallowing function after altered fractionation radiotherapy for head and neck carcinoma. Journal Hong Kong College of Radiologists 8(4):207–213
7.
Zurück zum Zitat Ang KK, Peters LJ, Weber RS, Maor MH, Morrison WH, Wendt CD et al (1990) Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys 19(6):1339–1345PubMedCrossRef Ang KK, Peters LJ, Weber RS, Maor MH, Morrison WH, Wendt CD et al (1990) Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys 19(6):1339–1345PubMedCrossRef
8.
Zurück zum Zitat Denham JW, Peters LJ, Johansen J, Poulsen M, Lamb DS, Hindley A et al (1999) Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer? Radiother Oncol 52(2):157–164PubMedCrossRef Denham JW, Peters LJ, Johansen J, Poulsen M, Lamb DS, Hindley A et al (1999) Do acute mucosal reactions lead to consequential late reactions in patients with head and neck cancer? Radiother Oncol 52(2):157–164PubMedCrossRef
9.
Zurück zum Zitat Dörr W, Hendry JH (2001) Consequential late effects in normal tissues. Radiother Oncol 61(3):223–231PubMedCrossRef Dörr W, Hendry JH (2001) Consequential late effects in normal tissues. Radiother Oncol 61(3):223–231PubMedCrossRef
10.
Zurück zum Zitat Pignon J, Maître A, Maillard E, Bourhis J (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92:4–14PubMedCrossRef Pignon J, Maître A, Maillard E, Bourhis J (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92:4–14PubMedCrossRef
11.
Zurück zum Zitat Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS et al (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26(21):3582–3589PubMedCrossRef Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS et al (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26(21):3582–3589PubMedCrossRef
12.
Zurück zum Zitat Graner D, Foote R, Kasperbauer J, Stoeckel R, Okuno S, Olsen K et al (2003) Swallow function in patients before and after intra-arterial chemoradiation. Laryngoscope 113(3):573–579PubMedCrossRef Graner D, Foote R, Kasperbauer J, Stoeckel R, Okuno S, Olsen K et al (2003) Swallow function in patients before and after intra-arterial chemoradiation. Laryngoscope 113(3):573–579PubMedCrossRef
13.
Zurück zum Zitat Kotz T, Costello R, Li Y, Posner M (2004) Swallowing dysfunction after chemoradiation for advanced squamous cell carcinoma of the head and neck. Head Neck 26(4):365–372PubMedCrossRef Kotz T, Costello R, Li Y, Posner M (2004) Swallowing dysfunction after chemoradiation for advanced squamous cell carcinoma of the head and neck. Head Neck 26(4):365–372PubMedCrossRef
14.
Zurück zum Zitat Lazarus C, Logemann JA, Pauloski BR, Rademaker AW, Helenowski IB, Vonesh EF et al (2007) Effects of radiotherapy with or without chemotherapy on tongue strength and swallowing in patients with oral cancer. Head Neck 29(7):632–637PubMedCrossRef Lazarus C, Logemann JA, Pauloski BR, Rademaker AW, Helenowski IB, Vonesh EF et al (2007) Effects of radiotherapy with or without chemotherapy on tongue strength and swallowing in patients with oral cancer. Head Neck 29(7):632–637PubMedCrossRef
15.
Zurück zum Zitat Goguen L, Posner M, Norris C, Tishler R, Wirth L, Annino D et al (2006) Dysphagia after sequential chemoradiation therapy for advanced head and neck cancer. Otolaryngol Head Neck Surg 134(6):916–922PubMedCrossRef Goguen L, Posner M, Norris C, Tishler R, Wirth L, Annino D et al (2006) Dysphagia after sequential chemoradiation therapy for advanced head and neck cancer. Otolaryngol Head Neck Surg 134(6):916–922PubMedCrossRef
16.
Zurück zum Zitat Logemann JA, Pauloski BR, Rademaker AW, Lazarus CL, Gaziano J, Stachowiak L et al (2008) Swallowing disorders in the first year after radiation and chemoradiation. Head Neck 30(2):148–158PubMedCrossRef Logemann JA, Pauloski BR, Rademaker AW, Lazarus CL, Gaziano J, Stachowiak L et al (2008) Swallowing disorders in the first year after radiation and chemoradiation. Head Neck 30(2):148–158PubMedCrossRef
17.
Zurück zum Zitat List MA, Siston A, Haraf D, Schumm P, Kies M, Stenson K et al (1999) Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. J Clin Oncol 17(3):1020–1028PubMed List MA, Siston A, Haraf D, Schumm P, Kies M, Stenson K et al (1999) Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. J Clin Oncol 17(3):1020–1028PubMed
18.
Zurück zum Zitat Oates J, Clark J, Read J, Reeves N, Gao K, Jackson M et al (2007) Prospective evaluation of quality of life and nutrition before and after treatment for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 133(6):533PubMedCrossRef Oates J, Clark J, Read J, Reeves N, Gao K, Jackson M et al (2007) Prospective evaluation of quality of life and nutrition before and after treatment for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 133(6):533PubMedCrossRef
19.
Zurück zum Zitat Lee H, Havrila C, Bravo V, Shantz K, Diaz K, Larner J et al (2008) Effect of oral nutritional supplementation on weight loss and percutaneous endoscopic gastrostomy tube rates in patients treated with radiotherapy for oropharyngeal carcinoma. Support Care Cancer 16(3):285–289PubMedCrossRef Lee H, Havrila C, Bravo V, Shantz K, Diaz K, Larner J et al (2008) Effect of oral nutritional supplementation on weight loss and percutaneous endoscopic gastrostomy tube rates in patients treated with radiotherapy for oropharyngeal carcinoma. Support Care Cancer 16(3):285–289PubMedCrossRef
20.
Zurück zum Zitat Hammerlid E, Wirblad B, Sandin C, Mercke C, Edstrom S, Kaasa S et al (1998) Malnutrition and food intake in relation to quality of life in head and neck cancer patients. Head Neck 20(6):540–548PubMedCrossRef Hammerlid E, Wirblad B, Sandin C, Mercke C, Edstrom S, Kaasa S et al (1998) Malnutrition and food intake in relation to quality of life in head and neck cancer patients. Head Neck 20(6):540–548PubMedCrossRef
21.
Zurück zum Zitat van den Berg M, Rasmussen-Conrad E, Gwasara G, Krabbe P, Naber A, Merkx M (2006) A prospective study on weight loss and energy intake in patients with head and neck cancer, during diagnosis, treatment and revalidation. Clin Nutr 25(5):765–772PubMedCrossRef van den Berg M, Rasmussen-Conrad E, Gwasara G, Krabbe P, Naber A, Merkx M (2006) A prospective study on weight loss and energy intake in patients with head and neck cancer, during diagnosis, treatment and revalidation. Clin Nutr 25(5):765–772PubMedCrossRef
22.
Zurück zum Zitat Schueller P, Schaefer U, Micke O, Willich N (1999) Results of simultaneous radiochemotherapy vs concomitant boost radiation in patients with inoperable cancer of the head and neck. Eur J Cancer 35(4):S174CrossRef Schueller P, Schaefer U, Micke O, Willich N (1999) Results of simultaneous radiochemotherapy vs concomitant boost radiation in patients with inoperable cancer of the head and neck. Eur J Cancer 35(4):S174CrossRef
23.
Zurück zum Zitat Cartmill B, Cornwell P, Ward EC, Davidson W, Porceddu SV (2011) A prospective investigation of swallowing, nutrition, and patient-rated functional impact following altered fractionation radiotherapy with concomitant boost for oropharyngeal cancer. Dysphagia (in press) Cartmill B, Cornwell P, Ward EC, Davidson W, Porceddu SV (2011) A prospective investigation of swallowing, nutrition, and patient-rated functional impact following altered fractionation radiotherapy with concomitant boost for oropharyngeal cancer. Dysphagia (in press)
24.
Zurück zum Zitat Dietitians Association of Australia and The Speech Pathology Association of Australia Limited (2007) Texture-modified foods and thickened fluids as used for individuals with dysphagia: Australian standardized labels and definitions. Nutr Diet 64(Suppl. 2):S53–S76 Dietitians Association of Australia and The Speech Pathology Association of Australia Limited (2007) Texture-modified foods and thickened fluids as used for individuals with dysphagia: Australian standardized labels and definitions. Nutr Diet 64(Suppl. 2):S53–S76
25.
Zurück zum Zitat Ward EC, Conroy A-L (1999) Validity, reliability, and responsivity of the royal brisbane hospital outcome measure for swallowing. Asia Pacific Journal of Speech Language and Hearing 4:109–129 Ward EC, Conroy A-L (1999) Validity, reliability, and responsivity of the royal brisbane hospital outcome measure for swallowing. Asia Pacific Journal of Speech Language and Hearing 4:109–129
27.
Zurück zum Zitat Rosenbek JC, Robbins JA, Roecker EB, Coyle JL, Wood JL (1996) A penetration-aspiration scale. Dysphagia 11(2):93–98PubMedCrossRef Rosenbek JC, Robbins JA, Roecker EB, Coyle JL, Wood JL (1996) A penetration-aspiration scale. Dysphagia 11(2):93–98PubMedCrossRef
28.
Zurück zum Zitat Ottery F (2000) Patient-generated subjective global assessment. In: McCallum P, Polisena C (eds) The clinical guide to oncology nutrition. The American Dietetic Association, Chicago, pp 11–23 Ottery F (2000) Patient-generated subjective global assessment. In: McCallum P, Polisena C (eds) The clinical guide to oncology nutrition. The American Dietetic Association, Chicago, pp 11–23
29.
Zurück zum Zitat Chen AY, Frankowshi R, Bishop-Leone J, Hebert T, Leyk S, Lewin J et al (2001) The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg 127(7):870–876PubMed Chen AY, Frankowshi R, Bishop-Leone J, Hebert T, Leyk S, Lewin J et al (2001) The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg 127(7):870–876PubMed
30.
Zurück zum Zitat Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579PubMed Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579PubMed
31.
Zurück zum Zitat Abdel-Wahab MMDP, Abitbol AMD, Lewin AMD, Troner MMD, Hamilton KP, Markoe AMDS (2005) Quality-of-life assessment after hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in inoperable and/or unresectable head and neck squamous cell carcinoma. Am J Clin Oncol 28(4):359–366PubMedCrossRef Abdel-Wahab MMDP, Abitbol AMD, Lewin AMD, Troner MMD, Hamilton KP, Markoe AMDS (2005) Quality-of-life assessment after hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in inoperable and/or unresectable head and neck squamous cell carcinoma. Am J Clin Oncol 28(4):359–366PubMedCrossRef
32.
Zurück zum Zitat Ackerstaff AH, Balm AJM, Rasch CRN, de Boer JP, Wiggenraad R, Rietveld DHF et al (2009) First-year quality of life assessment of an intra-arterial (RADPLAT) versus intravenous chemoradiation phase III trial. Head Neck 31(1):77–84PubMedCrossRef Ackerstaff AH, Balm AJM, Rasch CRN, de Boer JP, Wiggenraad R, Rietveld DHF et al (2009) First-year quality of life assessment of an intra-arterial (RADPLAT) versus intravenous chemoradiation phase III trial. Head Neck 31(1):77–84PubMedCrossRef
33.
Zurück zum Zitat Pauloski BR, Rademaker AW, Logemann JA, Newman L, MacCracken E, Gaziano J et al (2006) Relationship between swallow motility disorders on videofluorography and oral intake in patients treated for head and neck cancer with radiotherapy with or without chemotherapy. Head Neck 28(12):1069PubMedCrossRef Pauloski BR, Rademaker AW, Logemann JA, Newman L, MacCracken E, Gaziano J et al (2006) Relationship between swallow motility disorders on videofluorography and oral intake in patients treated for head and neck cancer with radiotherapy with or without chemotherapy. Head Neck 28(12):1069PubMedCrossRef
34.
Zurück zum Zitat Trotti A (2000) Toxicity in head and neck cancer: a review of trends and issues. Int J Radiat Oncol Biol Phys 47(1):1–12PubMedCrossRef Trotti A (2000) Toxicity in head and neck cancer: a review of trends and issues. Int J Radiat Oncol Biol Phys 47(1):1–12PubMedCrossRef
35.
Zurück zum Zitat van der Molen L, van Rossum M, Burkhead L, Smeele L, Hilgers F (2009) Functional outcomes and rehabilitation strategies in patients treated with chemoradiotherapy for advanced head and neck cancer: a systematic review. Eur Arch Otorhinolaryngol 266(6):889–900PubMedCrossRef van der Molen L, van Rossum M, Burkhead L, Smeele L, Hilgers F (2009) Functional outcomes and rehabilitation strategies in patients treated with chemoradiotherapy for advanced head and neck cancer: a systematic review. Eur Arch Otorhinolaryngol 266(6):889–900PubMedCrossRef
36.
Zurück zum Zitat Mittal BB, Pauloski BR, Haraf DJ, Pelzer HJ, Argiris A, Vokes EE et al (2003) Swallowing dysfunction: preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review. Int J Radiat Oncol Biol Phys 57(5):1219–1230PubMedCrossRef Mittal BB, Pauloski BR, Haraf DJ, Pelzer HJ, Argiris A, Vokes EE et al (2003) Swallowing dysfunction: preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review. Int J Radiat Oncol Biol Phys 57(5):1219–1230PubMedCrossRef
37.
Zurück zum Zitat Ringash J, Lockwood G, O'Sullivan B, Warde P, Bayley A, Cummings B et al (2008) Hyperfractionated, accelerated radiotherapy for locally advanced head and neck cancer: quality of life in a prospective phase I/II trial. Radiother Oncol 87(2):181–187PubMedCrossRef Ringash J, Lockwood G, O'Sullivan B, Warde P, Bayley A, Cummings B et al (2008) Hyperfractionated, accelerated radiotherapy for locally advanced head and neck cancer: quality of life in a prospective phase I/II trial. Radiother Oncol 87(2):181–187PubMedCrossRef
38.
Zurück zum Zitat Gillespie M, Brodsky M, Day T, Lee F, Martin-Harris B (2004) Swallowing-related quality of life after head and neck cancer treatment. Laryngoscope 114(8):1362–1367PubMedCrossRef Gillespie M, Brodsky M, Day T, Lee F, Martin-Harris B (2004) Swallowing-related quality of life after head and neck cancer treatment. Laryngoscope 114(8):1362–1367PubMedCrossRef
39.
Zurück zum Zitat Pauloski BR, Rademaker AW, Logemann JA, Lazarus CL, Newman L, Hamner A et al (2002) Swallow function and perception of dysphagia in patients with head and neck cancer. Head Neck 24(6):555–565PubMedCrossRef Pauloski BR, Rademaker AW, Logemann JA, Lazarus CL, Newman L, Hamner A et al (2002) Swallow function and perception of dysphagia in patients with head and neck cancer. Head Neck 24(6):555–565PubMedCrossRef
40.
Zurück zum Zitat Logemann J, Pauloski B, Rademaker A, Colangelo L, Kahrilas P, Smith C (2000) Temporal and biomechanical characteristics of oropharyngeal swallow in younger and older men. J Speech Lang Hear Res 43(5):1264PubMed Logemann J, Pauloski B, Rademaker A, Colangelo L, Kahrilas P, Smith C (2000) Temporal and biomechanical characteristics of oropharyngeal swallow in younger and older men. J Speech Lang Hear Res 43(5):1264PubMed
Metadaten
Titel
Swallowing, nutrition and patient-rated functional outcomes at 6 months following two non-surgical treatments for T1–T3 oropharyngeal cancer
verfasst von
Bena Cartmill
Petrea Cornwell
Elizabeth Ward
Wendy Davidson
Sandro Porceddu
Publikationsdatum
01.09.2012
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 9/2012
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-011-1316-4

Weitere Artikel der Ausgabe 9/2012

Supportive Care in Cancer 9/2012 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Wie der Klimawandel gefährliche Pilzinfektionen begünstigt

24.05.2024 Candida-Mykosen Nachrichten

Dass sich invasive Pilzinfektionen in letzter Zeit weltweit häufen, liegt wahrscheinlich auch am Klimawandel. Ausbrüche mit dem Hefepilz Candida auris stellen eine zunehmende Gefahr für Immungeschwächte dar – auch in Deutschland.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.